JBS (NYSE:JBS - Get Free Report) had its target price lowered by equities researchers at UBS Group from $17.00 to $16.50 in a research report issued on Thursday, Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's price objective indicates a potential upside of 39.06% from the stock's previous close.
JBS has been the topic of a number of other research reports. Stephens cut their price objective on shares of JBS from $18.00 to $17.00 and set an "overweight" rating on the stock in a research note on Monday, August 17th. JPMorgan Chase & Co. dropped their price target on shares of JBS from $18.00 to $17.50 and set an "overweight" rating on the stock in a research note on Thursday, October 22nd. Wall Street Zen cut shares of JBS from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Finally, Weiss Ratings raised shares of JBS from a "sell (d+)" rating to a "hold (c-)" rating in a report on Friday, October 30th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $17.90.
Check Out Our Latest Report on JBS
JBS Trading Down 1.3%
Shares of NYSE JBS traded down $0.15 during midday trading on Thursday, hitting $11.87. The company's stock had a trading volume of 10,059,640 shares, compared to its average volume of 6,002,380. JBS has a 12-month low of $10.61 and a 12-month high of $18.65. The firm has a market cap of $9.22 billion, a P/E ratio of 18.25, a price-to-earnings-growth ratio of 3.24 and a beta of -1.54. The business's 50 day moving average is $12.26 and its two-hundred day moving average is $13.90. The company has a current ratio of 1.56, a quick ratio of 0.79 and a debt-to-equity ratio of 2.58.
JBS (NYSE:JBS - Get Free Report) last issued its earnings results on Monday, November 9th. The company reported $0.16 earnings per share for the quarter, missing analysts' consensus estimates of $0.26 by ($0.10). The firm had revenue of $22.74 billion for the quarter. JBS had a net margin of 0.76% and a return on equity of 7.62%. The firm's quarterly revenue was up .6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.54 earnings per share. As a group, equities research analysts expect that JBS will post 1.01 EPS for the current year.
Insider Transactions at JBS
In other JBS news, CFO Guilherme Cavalcanti sold 183,501 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $13.85, for a total value of $2,541,488.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Institutional Investors Weigh In On JBS
A number of large investors have recently made changes to their positions in JBS. Allworth Financial LP lifted its position in JBS by 2,483.2% during the third quarter. Allworth Financial LP now owns 20,588 shares of the company's stock worth $232,000 after buying an additional 19,791 shares in the last quarter. Anomaly Capital Management LP acquired a new position in JBS during the third quarter worth $80,650,000. Greenwich Wealth Management LLC purchased a new stake in JBS in the 3rd quarter valued at $160,000. Utah Retirement Systems increased its stake in shares of JBS by 6.2% in the 3rd quarter. Utah Retirement Systems now owns 18,074 shares of the company's stock worth $204,000 after acquiring an additional 1,058 shares during the last quarter. Finally, Cetera Investment Advisers raised its holdings in shares of JBS by 75.9% during the 3rd quarter. Cetera Investment Advisers now owns 122,279 shares of the company's stock worth $1,381,000 after acquiring an additional 52,765 shares during the period.
JBS Company Profile
(
Get Free Report)
JBS S.A. is a global food company focused on processing beef, pork, poultry and lamb. Its products include fresh and frozen meat, prepared and packaged foods, and value-added food products sold under brands such as Swift, Pilgrim's and Seara. The company also produces ingredients and other products from animal byproducts, including leather and collagen. Founded in 1953 in Anápolis, Brazil, JBS has grown into an international business with operations across the Americas, Europe, Australia and other markets.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider JBS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JBS wasn't on the list.
While JBS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.